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A commentary on
The unliganded glucocorticoid receptor positively regulates the tumor suppressor gene BRCA1
through GABP beta
by Ritter, H. D., Antonova, L., and Mueller, C. R. (2012). Mol. Cancer Res. 10, 558–569.
A significant event leading to the development of breast cancer is loss of BRCA1 function.
BRCA1 is a tumor suppressor involved in the maintenance of genomic stability and prevention
of cell transformation. Many studies showed that stress increases the binding of cortisol to the
glucocorticoid receptor (GR) (Ritter et al., 2012). Ritter et al. showed that GR interacts with
GABPβ at the BRCA1 promoter (Ritter et al., 2012). This, in turn, activates BRCA1 expression. The
study also showed that addition of hydrocortisone, which binds the GR, eliminates the interaction
between GR and GABPβ, causing a deficiency of the GABP transcription factor to the BRCA1 gene,
which decreases its expression, and increases the risk of breast cancer (see Figure 1A). We would
like to propose a second mechanism by which stress causes a deficiency of the GABP transcription
factor involving the presence of certain latent viruses in the cell. This event has been described in
2003 in a book on Microcompetition (Polansky, 2003).
Many viruses consist of a core binding sequence as part of their enhancers, termed the N-
box. When such a virus establishes a latent infection, the viral N-boxes bind the GABP·p300
transcription complex. Furthermore, since this complex is limiting, the viral N-boxes decrease
the availability of the complex to cellular genes. As a result, the cellular genes that are stimulated
by the GABP·p300 complex produce fewer proteins, and the genes that are suppressed by this
complex produce more proteins. The abnormal levels of these cellular proteins induce disease
(Polansky, 2003). The term “Microcompetition” describes the relationship between viral and
cellular regulatory elements.
It is interesting that many common viruses, which establish a latent infection, have a
strong N-box in their promoters/enhancers. These viruses include the Epstein-Barr virus (EBV),
Cytomegalovirus (CMV), Herpes Simplex Virus (HSV), Varicella Zoster Virus (VZV), Hepatitis B
Virus (HBV), Hepatitis C Virus (HCV), and the Human Papillomavirus (HPV). In fact, the CMV
has the strongest promoter/enhancer known to science. In order to estimate the power of the CMV
promoter, we will combine the results from a few studies. Results from Liu et al. (2004) can be
used to estimate the strength of the CMV promoter/enhancer, which includes the N-box, relative
to the strength of the promoter of the cellular platelet-derived growth factor-b chain (PDGF-b)
gene. Part B of Figure 1 in Liu et al. reports the expression level driven by the CMV E/P (that is, the
CMV enhancer/promoter) vs. those driven by the PDGF-b promoter in a variety of cells, including
the COS-7, KB3-1, U251, PC12, and C17.2 cells. A close inspection of the numbers on the y-axis,
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FIGURE 1 | Two pathways initiated by a stress signal lead to breast cancer. One pathway involves an increase in latent viral copy number (A). Another pathway
involves an increase in cortisol•GR binding (B). Both events lead to a decrease in GABPβ binding to the BRCA1 promoter, decrease in BRCA1 expression, and breast
cancer.
which are depicted logarithmically, suggests that the CMV
P/E is about 150-fold stronger than the PDGF-b promoter.
We suspect that the reason for the difference is the much
higher affinity that the CMV promoter/enhancer has to the
GABP·p300 transcription complex relative to the PDGF-b
promoter. Slobedman and Mocarski showed that during latency,
an infected cell harbors about 10 copies of the CMV (Slobedman
and Mocarski, 1999). Therefore, the impact of a latent infection
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with the CMV is equivalent to the introduction of 1500 copies of
additional PDGF-b genes into the cell. Adam et al. showed that
PDGF-b is susceptible to microcompetition with CMV (Adam
et al., 1996). Therefore, according to Microcompetition theory,
a latent CMV infection would result in a decrease in PDGF-b
transcription followed by a decrease in the concentration of the
expressed protein in the latently infected cell, ultimately leading
to disease.
A number of studies showed the presence of EBV in
breast cancer tissue. Mazouni et al. reported that 33.2% of
tumors analyzed contained the BamHIC sub-region of the
EBV genome which encodes the Epstein-Barr encoded RNAs.
Furthermore, EBV-positive tumors presented with a more
aggressive phenotype (Mazouni et al., 2011). Studies have also
shown a correlation betweenHPV and breast cancer. Damin et al.
reported HPV DNA detected in 24.75% of breast carcinomas
(Damin et al., 2004). El-Shinawi et al. reported that 78.6% of
inflammatory breast cancer (IBC) tissues were HCMV-DNA
positive, suggesting a possible role for HCMV in the pathobiology
of IBC (El-Shinawi et al., 2013).
Stress increases viral copy number in a cell infected with a
latent virus. This increase in viral copy number causes an increase
in GABP bound to viral enhancers. Microcompetition ensues,
decreasing the availability of GABP to the BRCA1 promoter,
resulting in GABP transcription factor deficiency. This, in turn,
decreases BRCA1 expression and increases the risk of breast
cancer (see Figure 1B).
Due to the prevalence of latent viral infection, we believe that
viral induced transcription factor deficiency is highly important,
and has a significant impact on an individual’s general health.
Most individuals harbor a latent viral infection exposing them to
transcription factor deficiency. Therefore, these individuals are at
risk of diseases that can be triggered by such deficiency, including
cancer.
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